Pharma News, Research & Solutions CSR News

Astellas Brings Light to the Lives of Cancer Patients

Blog
At Astellas, we are dedicated to supporting and improving the lives of those impacted by cancer. One of the ways we provide this support is by working with patient advocacy organizations, such as The Leukemia and Lymphoma Society (LLS) – the world's largest voluntary health agency dedicated to blood cancers, including leukemia, lymphoma, Hodgkin's disease and myeloma.
 

Novartis Rises to Second Place in 2018 Access to Medicine Index

Report highlights newly launched Novartis Access Principles to systematically integrate access strategies in research, development and delivery of new medicines
Summary: 

Novartis ranked second in the 2018 Access to Medicine Index (ATMi), up from 3rd place in 2016, in recognition of its long-standing efforts to improve worldwide access to healthcare. Novartis remained the industry leader in access-to-medicine management, and its newly launched Access Principles – which aim to systematically integrate access strategies in how the company researches, develops and delivers medicines globally – have been highlighted as an innovative practice. The Novartis CEO and members of the Executive Committee now also have access objectives as part of their individual objectives.

Press Release

Novartis ranked second in the 2018 Access to Medicine Index (ATMi), up from 3rd place in 2016, in recognition of its long-standing efforts to improve worldwide access to healthcare. Novartis remained the industry leader in access-to-medicine management, and its newly launched Access Principles – which aim to systematically integrate access strategies in how the company researches, develops and delivers medicines globally – have been highlighted as an innovative practice. The Novartis CEO and members of the Executive Committee now also have access objectives as part of their individual objectives.

American Chemical Society Presents Merck with Green Chemistry Challenge Award

Multimedia with summary

We're proud to be named a winner of the American Chemical Society's Green Chemistry Challenge Award. The award recognizes companies for innovative processes in reducing waste and the generation of hazardous materials.

Learn more about our green and sustainable science here: https://bit.ly/2OwNFW7 

Corporate Giving Increased for a Third Consecutive Year, up 15% Since 2015

Industry-leading corporate social investment survey of 252 companies confirms business’ commitment to stakeholder needs
Press Release

NEW YORK, October 30, 2018 /3BL Media/ — In the largest, most robust, industry-leading, and internationally-recognized research of corporate social investment, CECP: The CEO Force for Good, in association with The Conference Board, found in their annual Giving in Numbers: 2018 Edition report that leading corporations are intensifying efforts to meet key societal needs around the world.

Shire Says 'Thank You' to Clinical Research Patient Volunteers

Multimedia with summary

Shire conveys our gratitude to clinical research study participants, very important people who are directly responsible for helping potential new medicines become available to patients in need.

Learn more about Shire’s approach to clinical trials at https://www.shiretrials.com/

Albertsons Companies Pharmacies Release Online Education Tools With Aim to Vaccinate 1.5 Million People This Flu Season

Websites include new flu maps, facts, interactive content for better public understanding
Press Release

BOISE, Idaho, October 9, 2018 /3BL Media/ - To bolster the public’s awareness about flu vaccinations and the fact that many insurance plans will cover most or all of the cost, Albertsons Companies pharmacies have fully revamped their informational consumer flu websites with new features, easier navigation, and interactive tools this flu season.

Merck Announces “Safer Childbirth Cities” Initiative, Issues Call to Action to Reverse the Rise in U.S. Maternal Deaths

Merck for Mothers Commits Additional $10M to Support Locally Created Solutions to Improve Maternal Health and Reduce Disparities
Press Release

KENILWORTH, N.J., October 3 , 2018 /3BL Media/ – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today a new effort to support cities across the country to help women have a healthy pregnancy and safe childbirth. The “Safer Childbirth Cities” initiative is intended to reduce the number of maternal deaths and life-threatening childbirth events and narrow disparities in maternal health outcomes in the U.S.

Pedaling for a Cure

Team ScottsMiracle-Gro participates in Pelotonia’s 10th anniversary bike tour.
Blog

Over 100 associates from ScottsMiracle-Gro recently participated in Pelotonia.

Pelotonia is an annual bike tour and nonprofit organization based in Columbus, Ohio, that raises money for cancer research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

The associate group, known as Team ScottsMiracle-Gro, has been raising money for Pelotonia since the beginning of the year. Hundreds of associates from around the world have made donations to this year’s team.

Merck Foundation Supports New Programs to Improve Care for Alzheimer’s Patients and Caregivers in the United States

Press Release

KENILWORTH, N.J., August 15, 2018 /3BL Media/ -- The Merck Foundation (the Foundation) is supporting two new programs to improve the health and wellbeing of vulnerable individuals living with Alzheimer’s disease and their caregivers. With a focus on underserved rural and urban populations in New England and Minnesota, these programs are part of the Foundation’s $5 million effort to reduce disparities in health care for underserved communities affected by Alzheimer’s.

Merck Reinforces Commitment to Responsible Pricing

Press Release

KENILWORTH, N.J., July 20, 2018 /3BL Media/ -- Merck (NYSE:MRK), known as MSD outside the United States and Canada, has a long history of responsible pricing. In 2017, Merck issued its second annual Pricing Action Transparency Report, which showed that net prices across Merck’s U.S. product portfolio declined by 1.9 percent. We believe that further changes are still necessary to help reduce patient out-of-pocket costs. To demonstrate our commitment to achieving this goal, we are making the following announcement:

Pages

Subscribe to Pharma News, Research & Solutions